Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPY2R | P49146 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23006350 | 0.90 | GPR119 (0.35) | DPP4CYP19A1KDM4ECNR1CNR2 | |
| SCHEMBL23006607 | 0.86 | SSTR4 (0.33) | CHRM3SSTR4 | |
| SCHEMBL28771328 | 0.86 | DPP4 (0.32) | DPP4GAAKMT2AKDM4E | |
| SCHEMBL22982348 | 0.81 | CHRM3 (0.36) | DPP4CYP19A1CHRM3GAAKMT2A | |
| SCHEMBL22982841 | 0.78 | TP53 (0.32) | GAAKMT2AKDM4ECNR1CNR2 | |
| SCHEMBL22982839 | 0.78 | TP53 (0.32) | GAAKMT2AKDM4ECNR1CNR2 | |
| SCHEMBL22982842 | 0.78 | TP53 (0.32) | GAAKMT2AKDM4ECNR1CNR2 | |
| SCHEMBL22983091 | 0.78 | CYP19A1 (0.33) | DPP4CYP19A1GAAKMT2AKDM4E | |
| SCHEMBL22983001 | 0.77 | ALDH1A1 (0.34) | CHRM3GAAKMT2AKDM4EMEN1 | |
| SCHEMBL22982905 | 0.74 | CXCR2 (0.34) | CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4013759-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2022-06-22 | — | — | EP | disclosed |
| WO-2021030556-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2021-02-18 | — | — | WO | disclosed |